Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAvenue Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$1.05 | -$1.05 | -$1.05 |
| Q2 2024 | 1 | -$0.94 | -$0.94 | -$0.94 |
| Q3 2024 | 1 | -$0.57 | -$0.57 | -$0.57 |
Avenue Therapeutics, Inc. Earnings Date And Information
Avenue Therapeutics, Inc. last posted its earnings results on Thursday, November 14th, 2024. The company reported $-1.92 earnings per share for the quarter, missing analysts' consensus estimates of $-0.94 by $0.98. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Avenue Therapeutics, Inc. has generated $-74 earnings per share over the last year ($-73.48 diluted earnings per share) and currently has a price-to-earnings ratio of -0.21. Avenue Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based on prior year's report dates.
Avenue Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.94 | -$1.92 | -0.98 | $0 | $0 |
| 08/09/2024 | Q2 2024 | -$1.05 | -$6.43 | -5.38 | $0 | $0 |
| 05/15/2024 | Q1 2024 | -$9.00 | -$7.72 | 1.28 | $0 | |
| 03/18/2024 | Q4 2023 | -$0.10 | $0.03 | 0.13 | $0 | |
| 11/13/2023 | Q3 2023 | -$0.26 | $0.06 | 0.32 | $0 | |
| 08/11/2023 | Q2 2023 | -$0.52 | $0 | |||
| 05/12/2023 | Q1 2023 | -$0.13 | -$1.57 | -1.44 | $0 | |
| 03/31/2023 | Q4 2022 | $3.57 | $0 | |||
| 11/10/2022 | Q3 2022 | -$0.45 | $0 | |||
| 08/15/2022 | Q2 2022 | -$0.41 | $0 | |||
| 05/16/2022 | Q1 2022 | -$2.04 | $0 | |||
| 03/25/2022 | Q4 2021 | -$0.75 | $0 | |||
| 11/15/2021 | Q3 2021 | -$0.79 | $0 | |||
| 08/16/2021 | Q2 2021 | -$0.86 | $0 | |||
| 05/17/2021 | Q1 2021 | -$0.90 | -$0.90 | 0 | $0 | |
| 03/31/2021 | Q4 2020 | -$0.90 | $0 | |||
| 11/04/2020 | Q3 2020 | -$112.73 | -$0.93 | 111.8 | $0 | |
| 08/14/2020 | Q2 2020 | -$112.73 | -$1.72 | 111.01 | $0 | |
| 05/11/2020 | Q1 2020 | -$191.63 | -$1.13 | 190.5 | $0 | |
| 03/30/2020 | Q4 2019 | -$4.95 | $0 |
Avenue Therapeutics, Inc. Earnings: FAQ's
When is Avenue Therapeutics, Inc.'s earnings date?
Avenue Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based off last year's report dates.
How can I listen to Avenue Therapeutics, Inc.'s earnings conference
call?
The conference call for Avenue Therapeutics, Inc.'s latest earnings report can be listened to online.
How can I read Avenue Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Avenue Therapeutics, Inc.'s latest earnings report can be read online.
How much profit does Avenue Therapeutics, Inc. generate each year?
Avenue Therapeutics, Inc. (:ATXI) has a recorded net income of $0. Avenue Therapeutics, Inc. has generated $-73.6 earnings per share over the last four quarters.
What is Avenue Therapeutics, Inc.'s price-to-earnings ratio?
Avenue Therapeutics, Inc. (:ATXI) has a price-to-earnings ratio of -0.21 and price/earnings-to-growth ratio is 0.02.